Purpose:  To demonstrate the outcomes of carotid  artery  stenting  (CAS) in treatment of symptomatic patients with significant extracranial carotid artery stenosis (>70%)  as our early experience in 15 cases. Methods: Between  July 2007 to January  2011, 15 patients  for whom  successful  15 CAS procedures  were done for symptomatic  internal carotid artery stenosis more than 70%, were included in the study. All patients underwent pre-procedural assessment in the form of complete history taking, neurological examination, colour  duplex ultrasonography (CDU) of carotid arteries, magnetic resonance angiography of carotid arteries and diffusion weighted magnetic resonance imaging (DW-MRI) of the brain. After  CAS,  patients  underwent neurological examination at the day of procedure, DW-MRI  ofthe brain  within  72 hours,  and clinical examination and  CDU  of  carotid  arteries at  one  month,  6 months  and  then  annually. Results: Post- procedural death rate was 6.7%. One patient (6.7%)  developed stroke after CAS. New DW-MRI lesions of the brain were found in 5 patients (33.3%)  after CAS, four of them (80%) remained  asymptomatic  and were of small volume lesions. Haemorrhagic lesion of the brain was found in one patient (6.7%)  following  CAS and was asymptomatic. Stented carotid arteries remained patent in the remaining 14 survived patients with no new neurologic deficits up to one year of follow up following CAS. Conclusion: Our early experience in using CAS in treatment of symptomatic carotid artery stenosis is promising. CAS seems to be effective and relatively safe therapeutic option in the short and intermediate terms. However, long term risks remain to be determined. As with other new procedures, it is hoped that with increasing experience, we will be able to better identify patients likely to benefit from the procedure, become more comfortable at catheter manipulation and  thereby  reduce  incidence of technical failures and  complications of the procedure.